This review is aimed to provide a comprehensive perspective of the metabolites of TCM improving IR and possessing therapeutic potential for hyperglycemia in T2DM by targeting the PI3K/AKT signaling pathway. Here, AKT1 is linked to type 2 diabetes mellitus.